Search for: "Aaron Barkoff"
Results 21 - 30
of 30
Sorted by Relevance
|
Sort by Date
15 Apr 2010, 9:16 pm
Cir. 2010) by Jim Wasicak and Aaron Barkoff In the Medicare Modernization Act of 2003, Congress gave ANDA applicants who have been sued for patent infringement the statutory right to file a counterclaim seeking the delisting of the patent from the Orange Book: If an owner of the patent or the holder of the [NDA] for the drug that is claimed by the patent or a use of which is claimed by the patent brings a patent infringement action against the [ANDA] applicant, the… [read post]
4 Nov 2011, 9:35 pm
The seminar will offer presentations on the following topics: • AIA's Impact on the Biotech/Chemical Prosecution Practice -- Alisha Bull of Whyte Hirschboeck Dudek • Joint Direct Infringement and the Biotech Practice -- Adam Kelly of Loeb & Loeb • An Examination and Discussion of Centocor v Abbott -- Aaron Barkoff of McAndrews Held & Malloy... [read post]
21 Jun 2007, 5:52 am
I continue to enjoy: Just a Patent Examiner Peter Zura's 271 Blog Fire of Genius - Professor Miller Patent Prospector Patent Search Expert and Economist Gary Odom OrangeBookBlog - Aaron Barkoff PatentDocs A genuine discussion of biotech and pharma patent issues And many others . . . [read post]
11 Mar 2007, 6:30 am
Thomas Ichim on YouTube discussing stem cell patents Aaron Barkoff on Bloomberg TV discussing reverse payment settlements. [read post]
11 Dec 2006, 6:12 am
The OBB is written by two more Docs, Aaron Barkoff, PhD and David Harper, PhD. [read post]
22 May 2008, 8:52 am
Articles include: Aaron Barkoff, Patent Litigation Under a Future Biosimilars Act Kevin Noonan, Follow-on Biologic Drugs and Patent Law: A Potential Disconnect? [read post]
8 May 2007, 12:49 pm
Links: University of Missouri-Columbia Law School MBHB: www.mbhb.com Two Other Blogs Run by MBHB Attorneys: Orange Book Blog, by Aaron Barkoff ("Covering the intersection of Patent Law and FDA Law"). [read post]
30 Aug 2011, 10:07 pm
” Aaron Barkoff notes that the opinion aligns the obviousness analysis for formulation claims (for known compounds) with that of claims for novel compounds. [read post]
18 Sep 2007, 2:49 pm
Aaron Barkoff of the Orange Book Blog said that he wondered if generic companies would try to get the legislation delayed until the next administration. [read post]
16 Oct 2006, 9:44 pm
” Paul Berghoff, Jeremy Noe, and Aaron Barkoff (of OrangeBookBlog) are on the brief. [read post]
